healthcare

Should AbbVie Be More Concerned About Its California Case for Humira?

Posted: September 19, 2018 at 1:50 pm

AbbVie Inc. (NYSE: ABBV) shares took a dip on Wednesday after it was announced that the pharmaceutical giant would be facing a lawsuit from the California Department of Insurance in ...
Read Full Story »

Clovis Finally Faces the Music for Fraudulent Lung Cancer Drug Results

Posted: September 19, 2018 at 1:00 pm

Clovis Oncology Inc. (NASDAQ: CLVS) shares might not be showing it now, but the company is facing some heat from the U.S. Securities and Exchange Commission (SEC). The company, its ...
Read Full Story »

Pot Grower Tilray Still Zooming

Posted: September 19, 2018 at 9:45 am

Canada-based marijuana grower Tilray Inc. (NASDAQ: TLRY) added nearly 30% to its share price on Tuesday to close at $154.98, after posting a new post-IPO high of $155.10. In Wednesday's ...
Read Full Story »

Why Tilray Shares Are Getting Even Higher

Posted: September 18, 2018 at 11:55 am

Tilray Inc. (NASDAQ: TLRY) continued its incredible rally with shares up massively on Tuesday after the U.S. Drug Enforcement Administration granted approval for the company to import a cannabinoid study ...
Read Full Story »

Why Viking Therapeutics Fatty Liver Study More Than Doubled Shares

Posted: September 18, 2018 at 9:40 am

Viking Therapeutics Inc. (NASDAQ: VKTX) shares more than doubled on Tuesday after the company announced results from its midstage non-alcoholic fatty liver disease (NAFLD) trial. Specifically, Viking announced positive topline ...
Read Full Story »

CRISPR Therapeutics Partners Up to Take on Diabetes

Posted: September 17, 2018 at 1:45 pm

CRISPR Therapeutics A.G. (NASDAQ: CRSP) shares dipped on Monday after the company announced a collaboration with ViaCyte focused on the discovery, development and commercialization of gene-edited allogeneic stem cell therapies ...
Read Full Story »

Urovant Closes in on IPO

Posted: September 17, 2018 at 9:40 am

Urovant Sciences has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company intends to price its 10 million ...
Read Full Story »

How Teva Won FDA Approval for Ajovy

Posted: September 17, 2018 at 9:35 am

Teva Pharmaceuticals Ltd. (NYSE: TEVA) shares made a solid gain early Monday after the company announced a critical approval by the U.S. Food and Drug Administration (FDA). Specifically, the FDA ...
Read Full Story »

Principia Biopharma Adds Even More Shares to IPO

Posted: September 14, 2018 at 11:05 am

Principia Biopharma has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company now intends to price its 6.25 ...
Read Full Story »

What This FDA Approval Means for STAAR Surgical

Posted: September 14, 2018 at 10:10 am

STAAR Surgical Co. (NASDAQ: STAA) shares made a handy gain on Friday after the firm announced a key approval by the U.S. Food and Drug Administration (FDA). The FDA granted ...
Read Full Story »

Allogene Therapeutics Files for IPO

Posted: September 14, 2018 at 9:45 am

Allogene Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO). No pricing details were given in the ...
Read Full Story »

Can Acorda Therapeutics Get Past This FDA Move?

Posted: September 13, 2018 at 11:20 am

Acorda Therapeutics Inc. (NASDAQ: ACOR) shares dipped on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) would be delaying its Prescription Drug User Fee Act ...
Read Full Story »

Why Progenics Shares Are Getting Crushed

Posted: September 13, 2018 at 10:55 am

Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) shares dropped sharply on Thursday after the company announced late-stage results from its prostate cancer study. Specifically, the firm announced top-line data from its Phase ...
Read Full Story »

Short Sellers Back Off Major Pharma Stocks

Posted: September 13, 2018 at 9:55 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Up the Ante in Major Biotechs

Posted: September 13, 2018 at 8:20 am

The short interest data are out for the most recent settlement date, August 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »